Global Enteral Nutrition Market Is Estimated To Witness High Growth Owing To Abbott Laboratories and Nestlé S.A.

Market Analysis Research Report on “Global Medical Nutrition Market” has been added to orbis research database.The Global Medical Nutrition Market status, future forecast, growth opportunity, key market and key players.

The study objectives are to present the Medical Nutrition development in United States, Europe and China.In 2018, the global Medical Nutrition market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/3091910The key players covered in this studyAbbott NutritionBaxter InternationalMead Johnson NutritionDanoneNestleNutricia…Market segment by Type, the product can be split intoEnteral NutritionParenteral NutritionMarket segment by Application, split intoInfantThe AgedPeople with MalnutritionOtherMarket segment by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaIf enquiry before buying this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/3091910The study objectives of this report are:To analyze global Medical Nutrition status, future forecast, growth opportunity, key market and key players.To present the Medical Nutrition development in United States, Europe and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market and key regions.About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.

We have vast database of reports from the leading publishers and authors across the globe.

We specialize in delivering customized reports as per the requirements of our clients.

We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization.

This helps our clients to map their needs and we produce the perfect required market research study for our clients.Contact Us:Hector CostelloSenior Manager – Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas – 75204, U.S.A.Phone No.

Key Factors Driving Growth in Enteral Feeding Devices Market: The market has evolved significantly owing to various technological advancements, such as programming and safety features in feeding pumps as well as user-friendly and portable feeding pumps.

Factors such as rising healthcare costs; surge in the number of preterm births; growth in the aging population; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period.

Growing Demand for Enteral Feeding in the Home Care Sector 3.

Increasing Prevalence of Chronic Diseases Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Enteral Feeding Devices market?

The oncology segment accounted for the largest share of the global market.

The increase in the prevalence of various types of cancers, especially head and neck cancers, cancers of the gastrointestinal system, lung cancer, and liver cancer, is expected to play a major role in the higher adoption of enteral feeding devices used to provide clinical nutrition to cancer patients.

Alternatively called tube feeding, intravenous nutrition is a method of supplying nutrients such as carbohydrates, proteins, water, fats, vitamins, and minerals to sufferers via tubes.

: A nasoenteral or nasogastric feeding tube is positioned through the nostril inside the belly, and a jejunostomy or gastrostomy is positioned without delay through the pores and skin withinside the belly.

As it's far tough for such sufferers to consume regular food or medication, tube feeding formula is needed to gain nutrition for patients hit by way of persistent circumstances such as head injury, cancer, strokes, and unbearably young youngsters.

A nasogastric tube is normally used for imparting nutrients, hydration, and vital medicinal drugs and is the maximum desired approach for short-time period feeding in the intense segment of stroke, consistent with NCBI.

Globally, chronic diseases such as diabetes, coronary heart disease, and cancer, as well as increasing health care spending, are primarily driving the growth of the global enteral nutrition market.

According to the American Diabetes Association (ADA), long-term use of dietary supplements that contain diabetes-specific formulations can reduce persistent health issues, such as heart disease, and according to the National Center for Biotechnology Information (NCBI), enteral nutrients can help with heart failure (CHF).

This study estimates the market size for 2018 and projects its demand till 2023.

Top-down and bottom-up approaches were used to validate the size of this market and estimate the size of other dependent submarkets.

Various secondary sources such as directories, industry journals, databases (such as D Hoovers, Bloomberg Business, and Factiva), and annual reports of companies have been used to identify and collect information useful for the study of the oncology nutrition market.According to the new market research report “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood)“,published by MarketsandMarkets™, oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.Major Growth Drivers:Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition formulas.Expected Revenue Growth:[92 Pages Report] The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.Accessories to Fuel the Growth of Oncology Nutrition MarketFactors such as shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967Browse in-depth TOC on “Oncology Nutrition Market”11– Tables23 – Figures92 – PagesThe report analyzes the oncology nutrition market by type of cancer and region.

Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017.

Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake.Thus, the enteral route is used for nutrition support.

With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased.

Enteral Feeding Devices Market OverviewEnteral feeding is referred to a nutritional therapy where nutrients are supplied directly to the gastrointestinal tract.

Different factors contributing to the ascension of the global enteral feeding devices market include increasing prevalence of the geriatric population, along with the rising incidence of chronic diseases across the globe.

There are several types of enteral tubes, such as nasoenteric feeding tubes, enterostomy feeding tubes, and oroenteric feeding tubes.

The nasoenteric feeding tubes include types of nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes.

Different indications of enteral feeding treatments include gastrointestinal diseases, cancer, neurological disorders, diabetes, and hypermetabolism.

Different types of cancer that require enteral feeding treatments include gastrointestinal cancer, liver cancer, head & neck cancer, esophageal cancer, and pancreatic cancer.

Enteral nutrition is administration of drugs or food through the gastrointestinal tract using feeding tubes.

It is prescribed to patients who are unable to consume food or take sufficient nutrients orally due to difficulty in swallowing or surgery but has a functional gastrointestinal tract.The enteral nutrients are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes generally, in an operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), and even at home for critically ill patients.

Enteral nutrients are prescribed to patients suffering from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others.

Download Free Sample Report @ https://www.radiantinsights.com/research/global-enteral-nutrition-market-research-report-2019/request-sample This report studies the global Enteral Nutrition market status and forecast, categorizes the global Enteral Nutrition market size (value & volume) by manufacturers, type, application, and region.

This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report• Abbott Laboratories• Nestle• Danone• Fresenius Kabi• Mead Johnson Nutrition• B. Braun Melsungen Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering• North America• Europe• China• Japan• Southeast Asia• India We can also provide the customized separate regional or country-level reports, for the following regions:• North America• United States• Canada• Mexico• Asia-Pacific• China• India• Japan• South Korea• Australia• Indonesia• Singapore• Rest of Asia-Pacific• Europe• Germany• France• UK• Italy• Spain• Russia• Rest of Europe• Central & South America• Brazil• Argentina• Rest of South America• Middle East & Africa• Saudi Arabia• Turkey• Rest of Middle East & Africa Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/global-enteral-nutrition-market-research-report-2019 On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into• Standard Protein diet• High Protein Supplement• Protein for Diabetes Care Patient• Others On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including• Hospital Sale• Retail• Online The study objectives of this report are:• To analyze and study the global Enteral Nutrition capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);• Focuses on the key Enteral Nutrition manufacturers, to study the capacity, production, value, market share and development plans in future.• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.• To define, describe and forecast the market by type, application and region.• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.• To identify significant trends and factors driving or inhibiting the market growth.• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market• To strategically profile the key players and comprehensively analyze their growth strategies.

This study estimates the market size for 2018 and projects its demand till 2023.

Top-down and bottom-up approaches were used to validate the size of this market and estimate the size of other dependent submarkets.

Various secondary sources such as directories, industry journals, databases (such as D Hoovers, Bloomberg Business, and Factiva), and annual reports of companies have been used to identify and collect information useful for the study of the oncology nutrition market.Major Growth Drivers:actors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition formulas.Expected Revenue Growth:[92 Pages Report] The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.Accessories to Fuel the Growth of Oncology Nutrition MarketFactors such as shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967The report analyzes the oncology nutrition market by type of cancer and region.

Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017.

Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake.Thus, the enteral route is used for nutrition support.

With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased.

 Ageing demographics, rapid technological developments, increasing adoption of home infusion therapies, favourable government policies and regulations are are key factors contributing to high CAGR of Home infusion therapy during forecast period.Market Size – USD 22.03 Billion in 2018, Market Growth - CAGR of 7.2%, Market Trends – Product launches and research for advanced Home infusion therapyAccording to current analysis of Reports and Data, the global Home Infusion Therapy Market was valued at USD 22.03 billion in 2018 and is expected to reach USD 38.41 billion by the year 2026, at a CAGR of 7.2%.

The advantage infusion offers is that it helps deliver a precise dose of the drug quickly and efficiently, and in a well-controlled manner throughout the body.

It is also used for irritating solutions; those can cause pain and even damage tissues if administered by subcutaneous or intramuscular injection.Moving care into the home is a very important step of change in healthcare.

Home infusion drugs are often not readily available through standard pharmacies and comparatively higher in cost.

However, increasing risk with patient's safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are the major hindrance for market growth during the forecast period.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2250The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns.

It also sheds light on recent technological developments, product advancements, and research and development activities in the region.The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies.

" The geriatric population is on a rise in the continent of North America owing to immigrants from World War II having fled to countries such as the United States of America and Canada have started reaching an old age in the current scenario, and their indigenous population adding to the geriatric the populace, the healthcare industry is adopting methods and technologies in accordance with them.

This report covers Infusion Therapy Devices Market Size by type and application, Infusion Therapy Devices Market share by top 5 companies and also the market share by start-ups during the forecast period.The IndustryARC report titled ‘Infusion Therapy Devices Market: By Type (Infusion type, Infusion method); By Pumps (Large volume pumps, Syringe pumps, Disposable pumps); By Accessories and consumables (I.V sets, Infusion sets, Needless connectors); By Application (Chemotherapy, Pain management, Enteral nutrition); By End users (Hospitals, Clinics, Home healthcare); By Geography - Forecast (2018-2023)’ has additional details about innovation in healthcare industry pertaining to infusion therapy devices which are being used in hospitals around the world.View Full Table of Contents of Infusion Therapy Devices Market:https://www.industryarc.com/Report/96/global-infusion-therapy-devices-infusion-pumps-market.htmlReport Price(Single User): US $3850Infusion Therapy Devices Market: Regional AnalysisInfusion therapy devices market has seen an extraordinary rise in North America in the recent past.

With severe lifestyle changes and unhealthy food emanating from composite cultures in these countries, people are getting frail with every passing day.

Another factor that is responsible for this demand share is technological advancements in infusion devices that are taking place inside medical research centres in the continent of North America.

Prominent medical institutes such as Johns Hopkins School of Medicine has a multitude of researchers working on this specific technology.Infusion Therapy Devices Market: Disruptive TrendsAccu-Chek Spirit Insulin Pump:Roche Diagnostics Corp, a Switzerland based medical company has come up with an insulin pump that is being praised for its ease of accessibility and flexible options.

It can easily be used by both patient and a nurse using navigation based operating system that can be customized according to the user’s knowledge level.Postmenopausal Osteoporosis:Switzerland based Novartis International AG, a well-known medical corporation in the world has invented an infusion therapy device called Reclast.

Global Heparin Market by Product (Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin (ULMWH)), by Application (Venous Thromboembolism, Coronary Artery Disease, Atrial Fibrillation, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) by Route of Administration (Intravenous, Subcutaneous), and by Region (North America, Europe, Asia Pacific, Latin America, MEA), - Global Forecasts 2017 to 2027 Research Report by AllTheResearch.The Global Heparin Market was valued at USD 6.5 billion in 2020 and is expected to reach USD 9.7 billion by 2027, growing at a CAGR of 5.9% during the forecast period, 2021 - 2027.Rapid Rise in medical emergencies is leading to high demand for Heparin after the Covid 19 impact.Heparin doses are often used to treat a wide range of health problems such as deep vein thrombosis, acute coronary syndrome, atrial fibrillation, pulmonary embolism, and even cardiopulmonary bypass and hemofiltration during cardiac surgery, this extravagant usage is propelling the market growth.

In addition, the supply of synthetic and semi-synthetic heparin mimetics that help treat cancer, coagulation, and inflammatory diseases is expected to provide a favorable opportunity for heparin adoption.Request a Sample Report- https://www.alltheresearch.com/sample-request/514 The Global Heparin Market Segmentation:The global heparin market is segmented into product, application, distribution channel, route of administration, and region.By Product TypeLow Molecular Weight Heparin (LMWH)Ultra-low Molecular Weight Heparin (ULMWH)By ApplicationVenous ThromboembolismCoronary Artery DiseaseAtrial FibrillationOthersBy Distribution ChannelHospital PharmaciesDrug Stores & Retail PharmaciesOnline PharmaciesBy Route of AdministrationIntravenousSubcutaneousBy RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaThe report provides with an in-depth analysis of market trends, financial analysis, segmentation analysis, company profiles, recent news and much more.

On the basis of applications, the coronary artery disease segment is accounted to dominate the market, owing to the increase in prevalence of heart- related disorders n past few years.Geographically, the North American region is dominating the market with highest revenue.

Report also covers analysis of some of the key players including Fresenius SE & Co KGaA, B. Braun Holding GmbH & Co. KG, Baxter International Inc., Dr. Reddy’s Laboratories Ltd., and Aspen Holdings among others.

Read More Information- https://www.alltheresearch.com/report/514/heparin-market-market Global Heparin Market Report Highlights.Based on distribution channel, the hospital pharmacies segment accounted for the highest share in 2020 which is accounted to the easy access and patients’ trust.By route of administration, the subcutaneous segment registered for the largest share in the market in 2020.

The growth is attributed to low cost associated with hospitalization compared to others.Despite of the economic slowdown in the past few years due to the COVID-19 crisis, the heparin market is witnessing the upsurge owing to the increased cases of respiratory diseases in the COVID-19 outbreak.Recent NewsBraun Holding GmbH & Co. KG in June 2021 has announced a acquisition over Nutrichem, in order to strengthen the market base for B. Braun Holding Gmbh & Co. KG in the enteral nutrition and clinical nutrition fields.In September 2019, the Baxter International Inc. announced its successful acquisition over Cheetah Medical, a company which provides non-invasive hemodynamic monitoring technologies.